Skip to main content

Eupraxia Pharmaceuticals Inc(EPRX-T)
TSX

Today's Change
Real-Time Last Update

Closing Bell: Eupraxia Pharmaceuticals Inc down on Tuesday (EPRX)

Automated Summaries - The Globe and Mail - Tue Apr 2, 4:02PM CDT

Today during trading, Eupraxia Pharmaceuticals Inc stock opened at $4.20 and closed at $3.94. It traded at a low of $3.91 to a high of $4.33.

Shares dipped -3.43 percent from the previous day's close of $4.08.

During the day across North America, the TSX Composite closed 0.08% at 22185.25, the S&P 500 closed -0.20% at 5243.77, the Dow Jones Industrial Average closed -0.60% at 39566.85 and the Nasdaq Composite closed 0.11% at 16396.83.

Eupraxia Pharmaceuticals Inc has listed on the Toronto Stock Exchange (TSX) under the ticker EPRX.

Trading volume was 52,201 on 128 total trades, with an average volume of 57,244 over the last 5 days.

Trading across the entire TSX saw 1,257 price advancers against 4,032 declines and 79 unchanged.

During the prior 52 weeks, EPRX.TO has traded as high as $9.10 (July 05,2023) and low as $3.89 (March 12,2024). Moreover, in the last 52 weeks, Eupraxia Pharmaceuticals Inc's shares have eased -6.86 percent, while they have shrunken -26.63% year-to-date.

Following today's trading, Eupraxia Pharmaceuticals Inc has a market capitalization of $145.34 million on a float of 35,622 shares outstanding. Its annual EPS is $-1.53.

Eupraxia Pharmaceuticals Inc is a TSX Biotechnology company headquartered in Victoria, CAN.

Based on 0.00 analysts, Eupraxia Pharmaceuticals Inc gets an average recommendation of "Strong Sell" according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe